Menu
← Oncology Approval Tracker
FDA DECISION ·
Cabozantinib tablets
cabozantinib · MSN Laboratories
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic of Cabometyx tablets for advanced renal cell carcinoma.
LAMPGEN ANALYSIS
Why it matters
A first generic approval can create a new procurement option for the same active ingredient and approved use. Check the specific label and commercial availability when discussing access.
What research teams should watch
Verify the product and tablet presentation before any substitution. Keep the regulatory approval date separate from formulary adoption and actual supply.
PRIMARY RECORDS